Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Gregory Harris (NPI 1568789261)

Field	Value
Entity Type	Individual
Organization	Gregory Harris
Address	255 W 5th St Sw
City	Rome
State	GA
ZIP	30165
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 21, 2010

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the claims record: Total Medicare revenue is $2M while Total Medicaid revenue is none (no Medicaid billing on file), meaning Medicare predominates the payer mix and the practice’s revenue exposure is concentrated to Medicare reimbursement. Analysts should treat Medicaid as absent when modeling payer exposure for this NPI.

Revenue concentration is extreme: the precomputed top‑3 Medicare codes account for 92.6% of the provider’s total Medicare revenue, led by J9271 at $1.3M (65.1%), J0897 at $488.6K (24.9%), and 99214 at $51.7K (2.6%). This concentration indicates that a very small set of drug and related visit codes drive nearly all Medicare income for this clinician.

The code mix and volumes point to a high‑throughput oncology infusion operation: J9271 (pembrolizumab) has 33.6K claims and $1.3M revenue and J0897 (denosumab) has 28.7K claims and $488.6K revenue, and chemotherapy administration codes such as 96413 ($33.1K, 372 claims) and add‑on 96417 ($6.6K, 144 claims) appear as part of the portfolio. Together with supportive oncology drugs like J2506 (pegfilgrastim, $21.2K, 252 claims), the pattern is consistent with a practice that focuses on infusion and biologic therapy administration rather than primarily office‑based management.

On competitive standing, this provider ranks well above peers for its top biologics: J0897 ranks #107 of 10057 providers nationally (99th percentile; extreme outlier), and J9271 ranks #78 of 1841 providers nationally (96th percentile; notably above typical national volume for this code). Those rankings indicate this NPI is a major national source of denosumab and pembrolizumab billing relative to other clinicians reporting these codes.

Workload and E&M mix suggest visits support infusion care rather than generating the largest share of revenue: 99214 appears with 588 claims and $51.7K revenue and ranks #36873 of 479517 providers nationally (92th percentile), while higher‑level new patient E&M codes (99205, 99204) and 99215 have relatively low claim counts. This supports the interpretation that revenue is driven by drug administration rather than by outpatient evaluation and management services.

Several ancillary procedure codes show unusually high throughput for non‑drug services, reinforcing an infusion‑center workflow: 36415 (venipuncture) has 1.3K claims and $10.6K revenue and ranks #1830 of 86467 providers nationally (98th percentile), and 96372 (therapeutic/prophylactic/subcutaneous injections) has 436 claims and $4.4K revenue and ranks #2073 of 58224 providers nationally (96th percentile). High percentiles on these technical services are consistent with frequent patient encounters for injections and blood draws.

The provider’s NPI tenure is long: NPI enumerated on 2010-04-21 (~16 years ago), indicating an established practice presence. Combined with the heavy concentration in high‑volume oncology biologics, this longevity supports the view of a stable, infusion‑oriented oncology practice rather than a new or transient operation.

From a payer/contracting perspective, the practice’s dependence on a very small set of high‑revenue codes is operationally important: $1.3M from J9271 and $488.6K from J0897 together dominate the $2M Medicare revenue pool, so changes in coverage, reimbursement, or utilization management for those drugs could disproportionately affect the provider’s Medicare revenue. For payers evaluating network value or utilization oversight, this NPI stands out as a concentrated source of pembrolizumab and denosumab administrations and merits targeted review for contracting and utilization patterns.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

46 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	33,600	$40	$1.3M
J0897	Injection, denosumab, 1 mg	28,740	$20	$488.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	590	$90	$51.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	370	$90	$33.1K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	250	$80	$21.2K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	1,330	$10	$10.6K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	870	$10	$8.7K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	1,200	$10	$8.4K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	40	$170	$6.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	50	$130	$6.7K

Showing 1–10 of 46

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 46 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Gregory Harris — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

46 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	40	15,200	$40	$767.3K
J0897	4	290	2,460	$20	$90.2K
J2506	10	10	460	$80	$34.1K
96413	29	160	170	$90	$20.3K
J3490	29	50	50	$320	$19.8K
99214	1,161	13,640	120	$80	$17.8K
J0185	11	20	7,150	$1	$13.9K
82784	11	30	120	$10	$11.1K
96365	156	210	110	$50	$10.8K
84443	203	590	130	$20	$10.6K

Showing 1–10 of 46

Related Providers

Other providers that share a Tax Identification Number (TIN) with Gregory Harris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Dimple Modi	GA	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Melissa Dillmon	GA	Hematology & Oncology Physician	$2M	$0
Dilawar Khan	GA	Hematology & Oncology Physician	$1.9M	$0
Jeffrey Peller	GA	Rheumatology Physician	$1.1M	$0
Harbin Clinic, LLC	GA	Ambulatory Surgical Clinic/Center	$754.6K	$0
Matthew Mumber	GA	Radiation Oncology Physician	$636.9K	$0
Rahul Garg	GA	Cardiovascular Disease Physician	$605K	$0
John Abdou	GA	Radiation Oncology Physician	$601.9K	$0
Charles Baggett	GA	Cardiovascular Disease Physician	$470.3K	$0
Nzeadibenma Uzochukwu	IL	Diagnostic Radiology Physician	$84K	$360.8K

Nearby Providers

Other providers in the same ZIP code as Gregory Harris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Dr. Miniyars Pediatrics, P.C.	GA	Pediatrics Physician	$0	$18.8M
Floyd Physicians, LLC	GA	Neonatal-Perinatal Medicine Physician	$0	$2.6M
Ear,nose,& Throat Of Northwest Georgia	GA	Otolaryngology Physician	$0	$2M
Amtran Medical Transport Inc	GA	Land Ambulance	$1.8M	$1.7K
Floyd Healthcare Management Inc	GA	Family Medicine Physician	$0	$1.3M
Travis Whitehead	GA	Emergency Medicine Physician	$70.8K	$702.1K
Kathrine Whitehead	GA	Emergency Medicine Physician	$59.8K	$626.1K
Surgery Center Of Rome, LP	GA	Ambulatory Surgical Clinic/Center	$681.8K	$0
Jason Smith	GA	Procedural Dermatology Physician	$445K	$0
Scott Mcdaniel	GA	Professional Counselor	$0	$423.4K

Gregory Harris — Billing Profile & Reimbursement Data

Sign up for Gregory Harris — Billing Profile & Reimbursement Data policy alerts

Gregory Harris — Billing Profile & Reimbursement Data

Sign up for Gregory Harris — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References